S-ketamin "Pfizer" injektionsvæske

DRUG2 trials

Sponsors

Rigshospitalet, Region Hovedstaden

Conditions

Out-of-hospital cardiac arrestintracerebral haemorrhagesubarachnoid haemorrhagetraumatic brain injury

Phase 3

KETamine sedation as neuroprotective agent following out-of-hospital cardiac arrest (OHCA) - the KETOHCA trial.

RecruitingCTIS2024-515987-29-00

RigshospitaletOut-of-hospital cardiac arrest

Start: 2024-12-11Target: 282Updated: 2025-04-15

Phase 4

S-KETamine vs. propofol for prehospital sedation of patients with severe Acute Brain Injury: The KETABI randomised trial

Not yet recruitingCTIS2026-525588-41-00

Region Hovedstadentraumatic brain injury, subarachnoid haemorrhage, intracerebral haemorrhage

Target: 284Updated: 2026-08-27